Biohaven Ltd.
BHVN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001935979
No open-market purchases or sales by Biohaven Ltd. insiders were filed in the last 90 days; 297 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Biohaven Ltd. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 297
- +22 vs. Q1 2026
- Shares held
- 143.5M
- +15.1M (+11.8%) vs. Q1 2026
- Total value
- $2.13B
- +$1.05B (+96.5%) vs. Q1 2026
- New holders
- 53
- 110 more added
- Sold out
- 31
- 87 more reduced
4 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BHVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 297 | $2.13B |
| Q1 2026 | 279 | $1.24B |
| Q4 2025 | 275 | $1.40B |
| Q3 2025 | 266 | $1.30B |
| Q2 2025 | 251 | $1.24B |
| Q1 2025 | 267 | $2.26B |
| Q4 2024 | 258 | $3.51B |
| Q3 2024 | 257 | $4.38B |
| Q2 2024 | 228 | $2.93B |
| Q1 2024 | 245 | $4.18B |
| Q4 2023 | 220 | $3.13B |
| Q3 2023 | 188 | $1.61B |
| Q2 2023 | 189 | $1.45B |
| Q1 2023 | 179 | $971.3M |
| Q4 2022 | 183 | $882.3M |
| Q3 2022 | 277 | $9.38B |
| Q2 2022 | 330 | $8.96B |
| Q1 2022 | 306 | $7.59B |
| Q4 2021 | 284 | $8.57B |
| Q3 2021 | 250 | $8.17B |
| Q2 2021 | 223 | $5.80B |
| Q1 2021 | 225 | $4.10B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Biohaven Ltd.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13,210,585 | $196.6M | 0.00% | +1,988,178+17.7% | Added |
| Suvretta Capital Management, LLC | 10,286,937 | $153.1M | 3.22% | 00.0% | Unchanged |
| Stifel Financial Corp | 9,941,165 | $147.9M | 0.12% | +2800.0% | Added |
| Jupiter Topco LLC | 8,584,675 | $127.9M | 0.05% | +8,584,675 | New |
| Woodline Partners LP | 7,660,280 | $114.0M | 0.35% | +7,359,891+2,450.1% | Added |
| State Street Corp | 6,947,034 | $103.4M | 0.00% | +328,231+5.0% | Added |
| Infinitum Asset Management, LLC | 6,250,000 | $93.0M | 9.46% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 4,190,195 | $62.4M | 0.04% | +1,343,002+47.2% | Added |
| AQR Capital Management LLC | 4,150,616 | $61.8M | 0.02% | +2,175,100+110.1% | Added |
| Geode Capital Management, LLC | 3,323,190 | $49.5M | 0.00% | +555,427+20.1% | Added |
| FMR LLC | 2,964,630 | $44.1M | 0.00% | +605,583+25.7% | Added |
| Royalty Pharma Sub-Manager, LLC | 2,936,507 | $43.7M | 18.06% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 2,610,000 | $38.8M | 1.99% | +850,000+48.3% | Added |
| Goldman Sachs Group Inc | 2,583,046 | $38.4M | 0.00% | +69,865+2.8% | Added |
| UBS Group AG | 2,518,827 | $37.5M | 0.01% | +1,092,400+76.6% | Added |
| Vanguard Portfolio Management LLC | 2,488,941 | $37.0M | 0.00% | +209,666+9.2% | Added |
| Knoll Capital Management, LLC | 2,352,520 | $35.0M | 16.33% | +23,918+1.0% | Added |
| Balyasny Asset Management LLC | 1,879,734 | $28.0M | 0.05% | −565,682−23.1% | Reduced |
| TCG Crossover Management, LLC | 1,779,952 | $26.5M | 0.64% | −2,851,365−61.6% | Reduced |
| Nuveen, LLC | 1,744,334 | $26.0M | 0.01% | +998,586+133.9% | Added |
| Rubric Capital Management LP | 1,721,493 | $25.6M | 0.23% | +1,721,493 | New |
| Citadel Advisors LLC | 1,619,676 | $24.1M | 0.01% | −103,431−6.0% | Reduced |
| Vanguard Capital Management LLC | 1,488,809 | $22.2M | 0.00% | +218,920+17.2% | Added |
| Bank of America Corp | 1,477,838 | $22.0M | 0.00% | +718,413+94.6% | Added |
| Price T Rowe Associates Inc | 1,456,851 | $21.7M | 0.00% | −760,324−34.3% | Reduced |
| ARS Investment Partners, LLC | 1,374,185 | $20.4M | 0.89% | −4,643−0.3% | Reduced |
| BNP Paribas Arbitrage, SA | 1,224,422 | $18.2M | 0.01% | −319,916−20.7% | Reduced |
| Capital Research Global Investors | 1,199,545 | $17.8M | 0.00% | −133,247−10.0% | Reduced |
| Northern Trust Corp | 1,186,211 | $17.7M | 0.00% | +184,801+18.5% | Added |
| MYDA Advisors LLC | 1,150,000 | $17.1M | 4.16% | −75,000−6.1% | Reduced |
| Charles Schwab Investment Management Inc | 1,109,283 | $16.5M | 0.00% | +168,206+17.9% | Added |
| StemPoint Capital LP | 1,064,200 | $15.8M | 2.74% | −2,124,782−66.6% | Reduced |
| Simplify Asset Management Inc. | 1,040,255 | $15.5M | 0.22% | +141,855+15.8% | Added |
| Adage Capital Partners GP, L.L.C. | 1,000,000 | $14.9M | 0.02% | −497,793−33.2% | Reduced |
| Qube Research & Technologies Ltd | 905,935 | $13.5M | 0.01% | −634,510−41.2% | Reduced |
| Voloridge Investment Management, LLC | 882,724 | $13.1M | 0.06% | −337,106−27.6% | Reduced |
| Morgan Stanley | 841,351 | $12.5M | 0.00% | −185,581−18.1% | Reduced |
| Vanguard Fiduciary Trust Co | 828,779 | $12.3M | 0.00% | +127,188+18.1% | Added |
| Ikarian Capital, LLC | 748,181 | $11.1M | 1.82% | +335,700+81.4% | Added |
| Erste Asset Management GmbH | 737,300 | $11.0M | 0.09% | +44,000+6.3% | Added |
| 5AM Venture Management, LLC | 738,972 | $11.0M | 3.82% | 00.0% | Unchanged |
| Integral Health Asset Management, LLC | 700,000 | $10.4M | 0.43% | −300,000−30.0% | Reduced |
| Marshall Wace, LLP | 651,349 | $9.69M | 0.01% | +298,744+84.7% | Added |
| Longaeva Partners L.P. | 599,903 | $8.93M | 0.26% | +599,903 | New |
| Sarissa Capital Management LP | 582,312 | $8.66M | 4.87% | +19,128+3.4% | Added |
| Pfizer Inc | 505,645 | $8.00M | 4.70% | 00.0% | Unchanged |
| Eversept Partners, LP | 515,804 | $7.68M | 0.42% | +515,804 | New |
| Trexquant Investment LP | 503,694 | $7.49M | 0.05% | −374,080−42.6% | Reduced |
| ADAR1 Capital Management, LLC | 501,687 | $7.47M | 0.35% | +456,910+1,020.4% | Added |
| Burkehill Global Management, LP | 500,000 | $7.44M | 0.27% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 491,918 | $7.32M | 0.01% | +118,819+31.8% | Added |
| JPMorgan Chase & Co | 469,832 | $7.11M | 0.00% | −33,733−6.7% | Reduced |
| Ieq Capital, LLC | 475,865 | $7.08M | 0.03% | +197,161+70.7% | Added |
| Raymond James Financial Inc | 465,895 | $6.93M | 0.00% | +19,284+4.3% | Added |
| Fiera Capital Corp | 445,769 | $6.63M | 0.02% | −328,399−42.4% | Reduced |
| Two Sigma Investments, LP | 443,775 | $6.60M | 0.00% | −742,939−62.6% | Reduced |
| Millennium Management LLC | 417,534 | $6.21M | 0.00% | −1,030,352−71.2% | Reduced |
| Bank of New York Mellon Corp | 386,939 | $5.76M | 0.00% | +79,695+25.9% | Added |
| Standard Life Aberdeen plc | 365,519 | $5.44M | 0.01% | −405,933−52.6% | Reduced |
| QVT Financial LP | 354,206 | $5.27M | 0.34% | +184,200+108.3% | Added |
| QTR Family Wealth, LLC | 337,432 | $5.02M | 1.75% | +1,452+0.4% | Added |
| Citigroup Inc | 314,453 | $4.68M | 0.00% | +279,216+792.4% | Added |
| Invesco Ltd. | 309,068 | $4.60M | 0.00% | +56,137+22.2% | Added |
| Algert Global LLC | 308,980 | $4.60M | 0.05% | −13,770−4.3% | Reduced |
| Royal Bank of Canada | 290,401 | $4.32M | 0.00% | +167,949+137.2% | Added |
| Susquehanna Portfolio Strategies, LLC | 269,967 | $4.02M | 0.06% | −40,680−13.1% | Reduced |
| HRT Financial LP | 268,529 | $4.00M | 0.01% | −565,137−67.8% | Reduced |
| Ameriprise Financial Inc | 268,227 | $3.99M | 0.00% | +212,887+384.7% | Added |
| Affinity Asset Advisors, LLC | 250,000 | $3.72M | 0.18% | +250,000 | New |
| Swiss National Bank | 249,000 | $3.71M | 0.00% | −9,600−3.7% | Reduced |
| NewEdge Wealth, LLC | 245,670 | $3.66M | 0.04% | −833−0.3% | Reduced |
| Jane Street Group, LLC | 238,403 | $3.55M | 0.00% | +9,959+4.4% | Added |
| Boothbay Fund Management, LLC | 230,684 | $3.43M | 0.06% | +102,822+80.4% | Added |
| Mariner, LLC | 212,539 | $3.16M | 0.00% | +117,163+122.8% | Added |
| Federated Hermes, Inc. | 202,040 | $3.01M | 0.00% | +202,040 | New |
| Deutsche Bank AG | 201,499 | $3.00M | 0.00% | +38,686+23.8% | Added |
| Susquehanna International Group, LLP | 181,182 | $2.70M | 0.00% | −124,385−40.7% | Reduced |
| New York State Common Retirement Fund | 180,651 | $2.69M | 0.00% | +20,400+12.7% | Added |
| Quantinno Capital Management LP | 170,749 | $2.54M | 0.00% | +49,195+40.5% | Added |
| Wells Fargo & Company | 170,270 | $2.53M | 0.00% | +77,229+83.0% | Added |
| XTX Topco Ltd | 170,163 | $2.53M | 0.03% | −238,319−58.3% | Reduced |
| California State Teachers Retirement System | 168,876 | $2.51M | 0.00% | −3,494−2.0% | Reduced |
| Rhumbline Advisers | 164,749 | $2.45M | 0.00% | +27,866+20.4% | Added |
| Sphera Funds Management Ltd. | 164,437 | $2.45M | 0.35% | −429,563−72.3% | Reduced |
| Cerity Partners LLC | 161,910 | $2.41M | 0.00% | +49,085+43.5% | Added |
| TD Asset Management Inc | 160,190 | $2.38M | 0.00% | −17,200−9.7% | Reduced |
| Manufacturers Life Insurance Company, The | 159,067 | $2.37M | 0.00% | −43,908−21.6% | Reduced |
| Empowered Funds, LLC | 152,060 | $2.26M | 0.01% | +3,304+2.2% | Added |
| Renaissance Technologies LLC | 150,752 | $2.24M | 0.00% | −10,200−6.3% | Reduced |
| Caption Management, LLC | 145,000 | $2.16M | 0.08% | +69,661+92.5% | Added |
| DAFNA Capital Management LLC | 137,593 | $2.05M | 0.39% | −708,142−83.7% | Reduced |
| Barclays PLC | 132,959 | $1.98M | 0.00% | +7,137+5.7% | Added |
| DCF Advisers, LLC | 130,000 | $1.93M | 0.51% | +6,500+5.3% | Added |
| Creative Planning | 118,599 | $1.76M | 0.00% | +62,486+111.4% | Added |
| Wealth Enhancement Advisory Services, LLC | 125,152 | $1.73M | 0.00% | +64,135+105.1% | Added |
| Mercer Global Advisors Inc | 114,594 | $1.71M | 0.00% | +65,369+132.8% | Added |
| Squarepoint Ops LLC | 109,161 | $1.62M | 0.00% | −68,517−38.6% | Reduced |
| Rafferty Asset Management, LLC | 105,374 | $1.57M | 0.00% | −99,174−48.5% | Reduced |
| SG Americas Securities, LLC | 101,920 | $1.52M | 0.00% | −163−0.2% | Reduced |
| Toronto Dominion Bank | 98,357 | $1.46M | 0.00% | +98,357 | New |